Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

unknown133%
completed267%

Recent Activity

0 active trials
Showing 3 of 3
unknownnot_applicable

In Vivo and in Vitro Anabolic Potential of Essential Amino Acids Following Resistance Exercise

NCT05754125
completednot_applicable

BCAA Supplemental Study

NCT03339232
completednot_applicable

Use of BCAA-rich Protein Supplements for Chronic Stroke Patients

NCT03244527

Clinical Trials (3)

Showing 3 of 3 trials
NCT05754125Not Applicable

In Vivo and in Vitro Anabolic Potential of Essential Amino Acids Following Resistance Exercise

Unknown
NCT03339232Not Applicable

BCAA Supplemental Study

Completed
NCT03244527Not Applicable

Use of BCAA-rich Protein Supplements for Chronic Stroke Patients

Completed

All 3 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
3